AIM
HSTO

Acrospire Investment Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Acrospire Investment Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-14
Closed -$16K – 1661
2017
Q2 		$16K Sell
14
-8
-36% -$9.74K 0.02% 1653
2017
Q1 		$26K Buy
22
+4
+22% +$3.86K 0.02% 1475
2016
Q4 		$19K Sell
18
-32
-64% -$14.5K 0.01% 1781
2016
Q3 		$20K Buy
50
+27
+117% +$11K 0.01% 1509
2016
Q2 		$9K Buy
23
+19
+475% +$9.31K 0.01% 1776
2016
Q1 		$2K Buy
+4
New +$1.55K ﹤0.01% 1949

Other funds holding HSTO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acrospire Investment Management's HSTO Position: Q3 2017 in Review

Acrospire Investment Management sold out of Histogen Inc. Common Stock (HSTO) in Q3 2017, closing a stake of 14 shares — an estimated $16K sold.

Acrospire Investment Management first reported a position in HSTO in Q1 2016 and held it in 6 quarters. The position peaked at $26K in Q1 2017. 78 funds tracked by Wall St. Rank hold HSTO as of Q3 2017.

  • Acrospire Investment Management reported no remaining Histogen Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 14 Histogen Inc. Common Stock shares in Q3 2017, an estimated $16K.
  • Acrospire Investment Management first reported a position in Histogen Inc. Common Stock in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's Histogen Inc. Common Stock position peaked at $26K in Q1 2017.
  • 78 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.